BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 15372250)

  • 1. PTPRC (CD45) C77G mutation does not contribute to multiple sclerosis susceptibility in Sardinian patients.
    Cocco E; Murru MR; Melis C; Schirru L; Solla E; Lai M; Rolesu M; Marrosu MG
    J Neurol; 2004 Sep; 251(9):1085-8. PubMed ID: 15372250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD45 (PTPRC) as a candidate gene in multiple sclerosis.
    Vyshkina T; Leist TP; Shugart YY; Kalman B
    Mult Scler; 2004 Dec; 10(6):614-7. PubMed ID: 15584483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An investigation of the C77G and C772T variations within the human protein tyrosine phosphatase receptor type C gene for association with multiple sclerosis in an Australian population.
    Szvetko AL; Jones A; Mackenzie J; Tajouri L; Csurhes PA; Greer JM; Pender MP; Griffiths LR
    Brain Res; 2009 Feb; 1255():148-52. PubMed ID: 19111528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of evidence for a role of the myelin basic protein gene in multiple sclerosis susceptibility in Sardinian patients.
    Cocco E; Mancosu C; Fadda E; Murru MR; Costa G; Murru R; Marrosu MG
    J Neurol; 2002 Nov; 249(11):1552-5. PubMed ID: 12420096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTPRC (CD45) is not associated with the development of multiple sclerosis in U.S. patients.
    Barcellos LF; Caillier S; Dragone L; Elder M; Vittinghoff E; Bucher P; Lincoln RR; Pericak-Vance M; Haines JL; Weiss A; Hauser SL; Oksenberg JR
    Nat Genet; 2001 Sep; 29(1):23-4. PubMed ID: 11528386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced frequency of a PTPRC (CD45) exon A mutation (77C-->G) in systemic sclerosis.
    Schwinzer R; Witte T; Hundrieser J; Ehlers S; Momot T; Hunzelmann N; Krieg T; Schmidt RE; Wonigeit K
    Genes Immun; 2003 Mar; 4(2):168-9. PubMed ID: 12618866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A point mutation in PTPRC is associated with the development of multiple sclerosis.
    Jacobsen M; Schweer D; Ziegler A; Gaber R; Schock S; Schwinzer R; Wonigeit K; Lindert RB; Kantarci O; Schaefer-Klein J; Schipper HI; Oertel WH; Heidenreich F; Weinshenker BG; Sommer N; Hemmer B
    Nat Genet; 2000 Dec; 26(4):495-9. PubMed ID: 11101853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of the PTPRC (CD45) mutation in the development of multiple sclerosis in the North West region of the United Kingdom.
    Nicholas RS; Partridge J; Donn RP; Hawkins C; Boggild MD
    J Neurol Neurosurg Psychiatry; 2003 Jul; 74(7):944-5. PubMed ID: 12810785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD45 and multiple sclerosis: the exon 4 C77G polymorphism (additional studies and meta-analysis) and new markers.
    Gomez-Lira M; Liguori M; Magnani C; Bonamini D; Salviati A; Leone M; Andreoli V; Trojano M; Valentino P; Savettieri G; Quattrone A; Pignatti PF; Momigliano-Richiardi P; Giordano M
    J Neuroimmunol; 2003 Jul; 140(1-2):216-21. PubMed ID: 12864992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of loci within the HLA region influences multiple sclerosis course in the Sardinian population.
    Marrosu MG; Cocco E; Costa G; Murru MR; Mancosu C; Murru R; Lai M; Sardu C; Contu P
    J Neurol; 2006 Feb; 253(2):208-13. PubMed ID: 16096810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for the genetic role of human leukocyte antigens in low frequency DRB1*1501 multiple sclerosis patients in Israel.
    Karni A; Kohn Y; Safirman C; Abramsky O; Barcellos L; Oksenberg JR; Kahana E; Karussis D; Chapman J; Brautbar C
    Mult Scler; 1999 Dec; 5(6):410-5. PubMed ID: 10618697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of an IFN-gamma gene (IFNG) polymorphism in multiple sclerosis in Europe: effect of population structure on association with disease.
    Goris A; Epplen C; Fiten P; Andersson M; Murru R; Sciacca FL; Ronsse I; Jäckel S; Epplen JT; Marrosu MG; Olsson T; Grimaldi LM; Opdenakker G; Billiau A; Vandenbroeck K
    J Interferon Cytokine Res; 1999 Sep; 19(9):1037-46. PubMed ID: 10505747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of children treated with haematopoietic-stem cell transplantations from donors expressing the rare C77G variant of the PTPRC (CD45) gene.
    Samaan S; Guérin-El Khourouj V; Auboeuf D; Peltier L; Pédron B; Ouachée-Chardin M; Gourgouillon N; Baruchel A; Dalle JH; Sterkers G
    Br J Haematol; 2011 Apr; 153(1):47-57. PubMed ID: 21323873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ICAM-1 gene is not associated with multiple sclerosis in sardinian patients.
    Marrosu MG; Schirru L; Fadda E; Mancosu C; Lai M; Cocco E; Cucca F
    J Neurol; 2000 Sep; 247(9):677-80. PubMed ID: 11081805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein tyrosine phosphatase receptor-type C exon 4 gene mutation distribution in an Italian multiple sclerosis population.
    Ballerini C; Rosati E; Salvetti M; Ristori G; Cannoni S; Biagioli T; Massacesi L; Sorbi S; Vergelli M
    Neurosci Lett; 2002 Aug; 328(3):325-7. PubMed ID: 12147336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosome 7q21-22 and multiple sclerosis: evidence for a genetic susceptibility effect in vicinity to the protachykinin-1 gene.
    Vandenbroeck K; Fiten P; Heggarty S; Goris A; Cocco E; Hawkins SA; Graham CA; Marrosu MG; Opdenakker G
    J Neuroimmunol; 2002 Apr; 125(1-2):141-8. PubMed ID: 11960650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PTPRC (CD45) variation and disease association studied using single nucleotide polymorphism tagging.
    Hennig BJ; Fry AE; Hirai K; Tahara H; Tamori A; Moller M; Hopkin J; Hill AV; Bodmer W; Beverley P; Tchilian E
    Tissue Antigens; 2008 May; 71(5):458-63. PubMed ID: 18312479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of linkage and association of alleles of proinflammatory cytokines genes IL-6, IFNg and TNF with multiple sclerosis using transmission disequilibrium test (TDT)].
    Makarycheva OIu; Tsareva EIu; Sudomoina MA; Kulakova OG; Bykova OV; Gol'tsova NV; Kuzenkova LM; Boĭko AN; Favorova OO
    Mol Biol (Mosk); 2010; 44(5):824-30. PubMed ID: 21090238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association of -330 interleukin-2 gene polymorphism and HLA-DR15 allele in Iranian patients with multiple sclerosis.
    Sayad A
    Int J Immunogenet; 2014 Aug; 41(4):330-4. PubMed ID: 24919928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enrichment for Northern European-derived multiple sclerosis risk alleles in Sardinia.
    Hadjixenofontos A; Gourraud PA; Bakthavachalam V; Foco L; Ticca A; Bitti P; Pastorino R; Bernardinelli L; McCauley JL
    Mult Scler; 2015 Oct; 21(11):1396-403. PubMed ID: 25921054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.